Victoria Socha

DocwireNews

Studies have shown that there are racial and ethnic disparities in the type of arteriovenous access (AVA)&mdash;arteriovenous fistula (AVF) versus arteriovenous graft (AVG)&mdash;used at incident hemodialysis. Melandrea L. Worsley, MD, and colleagues at Baylor College of Medicine, Houston, Texas, performed an analysis designed to assess racial and ethnic disparities in the anatomic location of hemodialysis AVA.Results were reported during a poster session at the American Society of Nephrology Kidney Week 2022. The poster was titled Racial and Ethnic Disparities in the Anatomic Location of Arteriovenous Access (AVA) for Hemodialysis (HD) Initiation.The researchers utilized clinical records of a large dialysis organization to evaluate patients &ge;16 years of age with incident end-stage renal disease who initiated hemodialysis at an outpatient center. Eligible patients initiated hemodialysis via an AVF or an AVG between 2006 and 2021. Patients who initiated hemodialysis via catheter access, who had multiple access types/locations reported at incident hemodialysis, were on peritoneal dialysis, or had a kidney transplant were excluded from the analysis.Race/ethnicity was categorized as White, Black, Hispanic, or other. Access location was identified as forearm or nonforearm. Associations of race/ethnicity with AVA forearm location were estimated using multivariable logistic regression. Race &acute; year interaction terms were used to assess AVA location trends over time.The eligible cohort included 42,373 participants. Of those, 22,596 were White, 10,729 were Black, 5054 were Hispanic, and 3994 were other races/ethnicities. Of the total cohort, 61% had diabetes and 6% had heart failure.In all race/ethnicity groups, there was a decrease in hemodialysis initiation via a forearm AVA over time: in 2006, 48% had a forearm AVA compared with 28% in 2021. An omnibus test for interaction of race &acute; calendar time was significant (P=.006).In 2021, compared with White patients, Black patients were 24% (95% CI, 16%-31%) less likely to initiate hemodialysis with a forearm AVA, and Hispanic patients were 19% (95% CI, 8%-28%) less likely to initiate hemodialysis with a forearm AVA. The findings were consistent within the subgroups with AVF and AVG access. Patients of other races were 23% (95% CI, 8%-41%) more likely to initiate hemodialysis with a forearm AVA than White patients.In summary, the researchers said, &ldquo;Racial disparities exist in the anatomic location of AVA used for initiation of outpatient hemodialysis, with Black and Hispanic patients being less likely than White patients to have a forearm location. Use of forearm AVA, generally the preferred anatomic location, has decreased over time across all racial/ethnic groups. Further investigation is needed into factors influencing these disparities and temporal trends.&rdquo;Source: Worsley ML, Winkelmayer WC, Erickson KF, Niu J, Gregg LP. Racial and ethnic disparities in the anatomic location of arteriovenous access (AVA) for hemodialysis (HD) initiation. FR-PO859. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2022; November 4, 2022; Orlando, Florida.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Disparities in Placement of Arteriovenous Access at Hemodialysis Initiation

ASN Kidney Week 2022

Studies have shown that there are racial and ethnic disparities in the type of arteriovenous access (AVA)—arteriovenous fistula (AVF) versus arteriovenous graft (AVG)—used ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe